南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

生物膜包被中空氧化铈纳米颗粒共递送DOX和ICG治疗三阴性乳腺癌

Biological membrane-coated hollow cerium oxide nanoparticles-mediated co-delivery of DOX and ICG for the treatment of triple-negative breast cancer

Manli Qu, Hongwei Ma, Jiazhen Li, Yong Huang, Wenjun He, Suqiong Liang, Lifang Huang, Chuqi Shao, Xiaowu Wang, Jingge Yang

Journal:MATERIALS TECHNOLOGY

IF:4

DOI:10.1080/10667857.2026.2652343

PMID:

Published:2026-04-04

research field:乳腺癌研究免疫治疗药物递送癌症治疗纳米医学

Abstract

Effective nano-platforms that integrate multiple therapeutic modalities are urgently needed to improve breast-cancer outcomes. Therefore, we engineered a breast cancer cell membrane (CM)-mimetic modified hollow cerium oxide nanoparticles (CM@H-CeO2/ID) for photothermal-chemo-immunotherapy of breast cancer. This platform achieves immune escape and active tumour targeting through homologous CM encapsulation; simultaneously, the hollow H-CeO2 carrier is utilised to co-carry ICG and DOX. Upon NIR irradiation, ICG produces hyperthermia that kills tumour cells and releases antigens; DOX then induces immunogenic cell death, and the Ce3+/Ce4+ redox cycling of H-CeO2 scavenges ROS to relieve immunosuppression. This tri-modal synergy markedly promotes dendritic-cell maturation and cytotoxic-T-cell infiltration, elicits systemic anti-tumour immunity and efficiently halts breast-tumour progression, offering a new paradigm for multimodal breast-cancer therapy.

本文使用的Yeasen产品

购物车
客服
转染试用